

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.31170662 |
| 2 | viral transcription (GO:0019083) | 5.38607022 |
| 3 | translational termination (GO:0006415) | 5.14764085 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 4.69414508 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.51386930 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.50271530 |
| 7 | maturation of SSU-rRNA (GO:0030490) | 4.37320852 |
| 8 | protein targeting to ER (GO:0045047) | 4.37296829 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 4.37091727 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.34983919 |
| 11 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.34983919 |
| 12 | translational elongation (GO:0006414) | 4.30144406 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.14879768 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 4.12247137 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.02361551 |
| 16 | viral life cycle (GO:0019058) | 4.00213337 |
| 17 | ribosomal large subunit biogenesis (GO:0042273) | 4.00028010 |
| 18 | positive thymic T cell selection (GO:0045059) | 3.95546073 |
| 19 | cellular protein complex disassembly (GO:0043624) | 3.87654474 |
| 20 | DNA deamination (GO:0045006) | 3.83630786 |
| 21 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.81290371 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 3.75201984 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 3.69577054 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.66321879 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66321879 |
| 26 | detection of external biotic stimulus (GO:0098581) | 3.63500781 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 3.61921832 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.58153977 |
| 29 | positive regulation of mast cell activation (GO:0033005) | 3.57291254 |
| 30 | translational initiation (GO:0006413) | 3.53861826 |
| 31 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.52436284 |
| 32 | positive regulation of mast cell degranulation (GO:0043306) | 3.52436284 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.46378009 |
| 34 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.43695212 |
| 35 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.42103526 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.40346510 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 3.37969378 |
| 38 | * regulation of antigen processing and presentation (GO:0002577) | 3.37631739 |
| 39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.34512843 |
| 40 | regulation of mast cell activation (GO:0033003) | 3.34122347 |
| 41 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.31650430 |
| 42 | microglial cell activation (GO:0001774) | 3.30151908 |
| 43 | * myeloid cell activation involved in immune response (GO:0002275) | 3.29632636 |
| 44 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.28907613 |
| 45 | protein complex disassembly (GO:0043241) | 3.27941311 |
| 46 | cytidine deamination (GO:0009972) | 3.25053623 |
| 47 | cytidine metabolic process (GO:0046087) | 3.25053623 |
| 48 | cytidine catabolic process (GO:0006216) | 3.25053623 |
| 49 | respiratory burst (GO:0045730) | 3.21702540 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.21465311 |
| 51 | detection of biotic stimulus (GO:0009595) | 3.19723629 |
| 52 | regulation of leukocyte degranulation (GO:0043300) | 3.19469816 |
| 53 | cellular extravasation (GO:0045123) | 3.19317747 |
| 54 | mature B cell differentiation involved in immune response (GO:0002313) | 3.18270967 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.16812009 |
| 56 | neutrophil activation (GO:0042119) | 3.11613801 |
| 57 | macromolecular complex disassembly (GO:0032984) | 3.08306115 |
| 58 | regulation of T cell tolerance induction (GO:0002664) | 3.08273579 |
| 59 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.06383008 |
| 60 | * positive regulation of antigen processing and presentation (GO:0002579) | 3.06067871 |
| 61 | response to host immune response (GO:0052572) | 3.05825852 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05825852 |
| 63 | regulation of tolerance induction (GO:0002643) | 3.03627049 |
| 64 | negative regulation of phagocytosis (GO:0050765) | 3.03315995 |
| 65 | leukocyte degranulation (GO:0043299) | 3.01872872 |
| 66 | response to interferon-beta (GO:0035456) | 3.01651155 |
| 67 | superoxide anion generation (GO:0042554) | 3.00772205 |
| 68 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.00394843 |
| 69 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.00086074 |
| 70 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.99492236 |
| 71 | positive T cell selection (GO:0043368) | 2.97788863 |
| 72 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.97254899 |
| 73 | granulocyte activation (GO:0036230) | 2.95844211 |
| 74 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.95187662 |
| 75 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.93606495 |
| 76 | cellular response to interferon-beta (GO:0035458) | 2.92751891 |
| 77 | B cell mediated immunity (GO:0019724) | 2.91347893 |
| 78 | cellular response to zinc ion (GO:0071294) | 2.91068093 |
| 79 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.90981856 |
| 80 | telomere maintenance via recombination (GO:0000722) | 2.89312510 |
| 81 | regulation of regulatory T cell differentiation (GO:0045589) | 2.88485572 |
| 82 | regulation of hypersensitivity (GO:0002883) | 2.88428520 |
| 83 | response to peptidoglycan (GO:0032494) | 2.88084038 |
| 84 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.86599053 |
| 85 | macrophage activation (GO:0042116) | 2.85987931 |
| 86 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.85496511 |
| 87 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.85180537 |
| 88 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.83954099 |
| 89 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.82956591 |
| 90 | protein targeting to membrane (GO:0006612) | 2.81662408 |
| 91 | cellular response to interferon-gamma (GO:0071346) | 2.81204266 |
| 92 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.80517001 |
| 93 | negative thymic T cell selection (GO:0045060) | 2.79793181 |
| 94 | response to type I interferon (GO:0034340) | 2.79009035 |
| 95 | type I interferon signaling pathway (GO:0060337) | 2.78596994 |
| 96 | cellular response to type I interferon (GO:0071357) | 2.78596994 |
| 97 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.78591021 |
| 98 | detection of molecule of bacterial origin (GO:0032490) | 2.78537226 |
| 99 | detection of other organism (GO:0098543) | 2.77199577 |
| 100 | leukocyte aggregation (GO:0070486) | 2.77145456 |
| 101 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.76777715 |
| 102 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.76468718 |
| 103 | regulation of respiratory burst (GO:0060263) | 2.75928017 |
| 104 | neutrophil mediated immunity (GO:0002446) | 2.75356972 |
| 105 | negative regulation of innate immune response (GO:0045824) | 2.74982866 |
| 106 | interferon-gamma production (GO:0032609) | 2.74511057 |
| 107 | negative T cell selection (GO:0043383) | 2.73935747 |
| 108 | * regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73754940 |
| 109 | T cell selection (GO:0045058) | 2.72443214 |
| 110 | mast cell activation (GO:0045576) | 2.71007171 |
| 111 | mRNA catabolic process (GO:0006402) | 2.70463110 |
| 112 | defense response to protozoan (GO:0042832) | 2.69956394 |
| 113 | translation (GO:0006412) | 2.69681228 |
| 114 | response to host defenses (GO:0052200) | 2.69124769 |
| 115 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69124769 |
| 116 | response to protozoan (GO:0001562) | 2.69038065 |
| 117 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.68238750 |
| 118 | interferon-gamma secretion (GO:0072643) | 2.64150640 |
| 119 | DNA strand elongation (GO:0022616) | 2.62151910 |
| 120 | lipoxygenase pathway (GO:0019372) | 2.61324951 |
| 121 | hepatocyte apoptotic process (GO:0097284) | 2.61128652 |
| 122 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.58282184 |
| 123 | dendritic cell migration (GO:0036336) | 2.57378407 |
| 124 | mitotic recombination (GO:0006312) | 2.56662500 |
| 125 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.54737135 |
| 126 | dendritic cell chemotaxis (GO:0002407) | 2.54292105 |
| 127 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.53928983 |
| 128 | T cell migration (GO:0072678) | 2.53335720 |
| 129 | regulation of B cell differentiation (GO:0045577) | 2.53191021 |
| 130 | positive regulation of B cell differentiation (GO:0045579) | 2.52208576 |
| 131 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.51499586 |
| 132 | RNA catabolic process (GO:0006401) | 2.51077174 |
| 133 | positive regulation of macrophage differentiation (GO:0045651) | 2.50519615 |
| 134 | positive regulation of interferon-alpha production (GO:0032727) | 2.47785174 |
| 135 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.45260507 |
| 136 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.44768183 |
| 137 | desmosome organization (GO:0002934) | 2.43962866 |
| 138 | sphingoid metabolic process (GO:0046519) | 2.43798975 |
| 139 | leukotriene metabolic process (GO:0006691) | 2.43260837 |
| 140 | actin nucleation (GO:0045010) | 2.43073594 |
| 141 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.43023306 |
| 142 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.41344097 |
| 143 | * myeloid dendritic cell activation (GO:0001773) | 2.39537582 |
| 144 | response to interferon-alpha (GO:0035455) | 2.39444486 |
| 145 | detection of bacterium (GO:0016045) | 2.38206161 |
| 146 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.36490580 |
| 147 | modulation by symbiont of host immune response (GO:0052553) | 2.36490580 |
| 148 | positive regulation by symbiont of host defense response (GO:0052509) | 2.36490580 |
| 149 | modulation by symbiont of host defense response (GO:0052031) | 2.36490580 |
| 150 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.36490580 |
| 151 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.36490580 |
| 152 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.35751660 |
| 153 | response to muramyl dipeptide (GO:0032495) | 2.33912760 |
| 154 | regulation of interferon-alpha production (GO:0032647) | 2.33789495 |
| 155 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.32410384 |
| 156 | regulation of cellular extravasation (GO:0002691) | 2.31423547 |
| 157 | reactive oxygen species biosynthetic process (GO:1903409) | 2.31396023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.99882329 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.61734144 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.32941122 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.85539673 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.58637221 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.23966701 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.81817458 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.81803269 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.64024510 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60058851 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.58394407 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.51245160 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.37043499 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34750745 |
| 15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.32305856 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.26973468 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.26696042 |
| 18 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.25343871 |
| 19 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23107682 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20920460 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19250692 |
| 22 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.19055689 |
| 23 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14826019 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.06873607 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.06680095 |
| 26 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.05585970 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.03578085 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.00357575 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98348267 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91374766 |
| 31 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89959808 |
| 32 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.89183204 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.85884273 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.84740126 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82459069 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.76189021 |
| 37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.69101071 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.67717214 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67383938 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.66594267 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.65546172 |
| 42 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.64511086 |
| 43 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60879913 |
| 44 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.60716045 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59716123 |
| 46 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.59045299 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57195513 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54904849 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.54572412 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54184502 |
| 51 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.54060572 |
| 52 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53831736 |
| 53 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.49586279 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48730178 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47717392 |
| 56 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.47009717 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.46582119 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.45594648 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.44711344 |
| 60 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.42866136 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41500035 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.40687886 |
| 63 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40173790 |
| 64 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39868505 |
| 65 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.38983546 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37927206 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37386463 |
| 68 | * MYB_26560356_Chip-Seq_TH1_Human | 1.36263290 |
| 69 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.34894246 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33362996 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.32932910 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28764135 |
| 73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.28242103 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27976250 |
| 75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27273740 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26611954 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26081783 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25008987 |
| 79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24946681 |
| 80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24505662 |
| 81 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.23206183 |
| 82 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.22497101 |
| 83 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22381550 |
| 84 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21838552 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20153624 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19431817 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19239682 |
| 88 | UTX_26944678_Chip-Seq_JUKART_Human | 1.18810315 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17800476 |
| 90 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16655008 |
| 91 | MYC_22102868_ChIP-Seq_BL_Human | 1.16187672 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15893719 |
| 93 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.15624590 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 1.14263024 |
| 95 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.14111537 |
| 96 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14004664 |
| 97 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13480647 |
| 98 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13238689 |
| 99 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13058065 |
| 100 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12859762 |
| 101 | P300_27268052_Chip-Seq_Bcells_Human | 1.12317565 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11361692 |
| 103 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11086358 |
| 104 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10755980 |
| 105 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.09832680 |
| 106 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.09137835 |
| 107 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08663112 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08418300 |
| 109 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.06700036 |
| 110 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05708144 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05299300 |
| 112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04713957 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04432865 |
| 114 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.04330538 |
| 115 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04160919 |
| 116 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03132075 |
| 117 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02137427 |
| 118 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01060919 |
| 119 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00634521 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00515204 |
| 121 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.00402442 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 0.99082860 |
| 123 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98530583 |
| 124 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98092713 |
| 125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97030845 |
| 126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96309760 |
| 127 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95146213 |
| 128 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94724213 |
| 129 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94649802 |
| 130 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94350930 |
| 131 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94291762 |
| 132 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93853079 |
| 133 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93029466 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92629594 |
| 135 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.92461787 |
| 136 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.92267478 |
| 137 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.91664082 |
| 138 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90800498 |
| 139 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85975451 |
| 140 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85205097 |
| 141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85103945 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.05754425 |
| 2 | * MP0002148_abnormal_hypersensitivity_rea | 3.15886487 |
| 3 | MP0009785_altered_susceptibility_to | 3.01411871 |
| 4 | MP0003436_decreased_susceptibility_to | 2.93951108 |
| 5 | MP0005671_abnormal_response_to | 2.91849509 |
| 6 | MP0003724_increased_susceptibility_to | 2.69576261 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.64126738 |
| 8 | * MP0005025_abnormal_response_to | 2.62589970 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.52274580 |
| 10 | MP0000685_abnormal_immune_system | 2.48099186 |
| 11 | MP0001800_abnormal_humoral_immune | 2.35902499 |
| 12 | * MP0002419_abnormal_innate_immunity | 2.33604379 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.33239423 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.33200284 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.32739261 |
| 16 | MP0002006_tumorigenesis | 2.30791843 |
| 17 | MP0001790_abnormal_immune_system | 2.24999277 |
| 18 | MP0005387_immune_system_phenotype | 2.24999277 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.23051758 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.21888073 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.21737725 |
| 22 | * MP0001819_abnormal_immune_cell | 2.21357020 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.21341444 |
| 24 | * MP0002723_abnormal_immune_serum | 2.21255015 |
| 25 | MP0002396_abnormal_hematopoietic_system | 2.19101393 |
| 26 | MP0000490_abnormal_crypts_of | 2.16801507 |
| 27 | MP0005174_abnormal_tail_pigmentation | 2.04440810 |
| 28 | MP0003693_abnormal_embryo_hatching | 1.94675956 |
| 29 | MP0004381_abnormal_hair_follicle | 1.92707069 |
| 30 | MP0006082_CNS_inflammation | 1.92592996 |
| 31 | MP0002405_respiratory_system_inflammati | 1.85390098 |
| 32 | MP0002398_abnormal_bone_marrow | 1.85142077 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.83939948 |
| 34 | MP0004947_skin_inflammation | 1.83632549 |
| 35 | MP0001873_stomach_inflammation | 1.82944156 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.82056594 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.81486209 |
| 38 | MP0001853_heart_inflammation | 1.74109217 |
| 39 | * MP0000716_abnormal_immune_system | 1.73539221 |
| 40 | MP0003075_altered_response_to | 1.62139513 |
| 41 | * MP0001845_abnormal_inflammatory_respons | 1.59411135 |
| 42 | MP0002132_abnormal_respiratory_system | 1.58141968 |
| 43 | MP0003866_abnormal_defecation | 1.55544906 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.55344582 |
| 45 | MP0001545_abnormal_hematopoietic_system | 1.55344582 |
| 46 | MP0002722_abnormal_immune_system | 1.55052677 |
| 47 | MP0003941_abnormal_skin_development | 1.51209209 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.50471343 |
| 49 | MP0000689_abnormal_spleen_morphology | 1.50239553 |
| 50 | * MP0002429_abnormal_blood_cell | 1.49316846 |
| 51 | MP0002796_impaired_skin_barrier | 1.48524466 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.45785252 |
| 53 | MP0000858_altered_metastatic_potential | 1.45108561 |
| 54 | MP0010094_abnormal_chromosome_stability | 1.42440630 |
| 55 | MP0008004_abnormal_stomach_pH | 1.39932125 |
| 56 | MP0002009_preneoplasia | 1.34684600 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.33551483 |
| 58 | MP0008057_abnormal_DNA_replication | 1.32087744 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.29590395 |
| 60 | MP0004957_abnormal_blastocyst_morpholog | 1.29372406 |
| 61 | MP0001216_abnormal_epidermal_layer | 1.24202166 |
| 62 | MP0002095_abnormal_skin_pigmentation | 1.24105989 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.20801577 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.20067899 |
| 65 | MP0003448_altered_tumor_morphology | 1.19200710 |
| 66 | MP0003828_pulmonary_edema | 1.16523343 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.15034946 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.14379869 |
| 69 | MP0008007_abnormal_cellular_replicative | 1.14298063 |
| 70 | * MP0008469_abnormal_protein_level | 1.14112509 |
| 71 | MP0003077_abnormal_cell_cycle | 1.13378622 |
| 72 | MP0008058_abnormal_DNA_repair | 1.11993935 |
| 73 | MP0005501_abnormal_skin_physiology | 1.11956169 |
| 74 | MP0009840_abnormal_foam_cell | 1.09702054 |
| 75 | MP0005058_abnormal_lysosome_morphology | 1.08213149 |
| 76 | MP0008260_abnormal_autophagy | 1.06938451 |
| 77 | MP0009764_decreased_sensitivity_to | 1.05815814 |
| 78 | MP0003303_peritoneal_inflammation | 1.05254416 |
| 79 | MP0003111_abnormal_nucleus_morphology | 1.04225875 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 1.01601445 |
| 81 | MP0002019_abnormal_tumor_incidence | 1.00355511 |
| 82 | MP0003186_abnormal_redox_activity | 0.98910451 |
| 83 | MP0002060_abnormal_skin_morphology | 0.98276140 |
| 84 | MP0004883_abnormal_blood_vessel | 0.95312047 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.94568079 |
| 86 | MP0003300_gastrointestinal_ulcer | 0.92241372 |
| 87 | MP0002098_abnormal_vibrissa_morphology | 0.92126078 |
| 88 | MP0001851_eye_inflammation | 0.92012617 |
| 89 | MP0000343_altered_response_to | 0.91757970 |
| 90 | MP0003191_abnormal_cellular_cholesterol | 0.91240392 |
| 91 | MP0005310_abnormal_salivary_gland | 0.90025908 |
| 92 | MP0002933_joint_inflammation | 0.89080776 |
| 93 | MP0001663_abnormal_digestive_system | 0.88368048 |
| 94 | MP0000383_abnormal_hair_follicle | 0.87060470 |
| 95 | MP0000604_amyloidosis | 0.85767239 |
| 96 | MP0001191_abnormal_skin_condition | 0.84313835 |
| 97 | MP0005083_abnormal_biliary_tract | 0.83283200 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.81805464 |
| 99 | MP0002254_reproductive_system_inflammat | 0.80684013 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.80530793 |
| 101 | MP0005451_abnormal_body_composition | 0.79193317 |
| 102 | MP0005164_abnormal_response_to | 0.79027145 |
| 103 | MP0002998_abnormal_bone_remodeling | 0.77534202 |
| 104 | MP0004510_myositis | 0.77218670 |
| 105 | MP0005360_urolithiasis | 0.76456290 |
| 106 | MP0003786_premature_aging | 0.76102530 |
| 107 | MP0006054_spinal_hemorrhage | 0.75743871 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.75521269 |
| 109 | MP0009931_abnormal_skin_appearance | 0.73082420 |
| 110 | MP0000477_abnormal_intestine_morphology | 0.72028239 |
| 111 | MP0009278_abnormal_bone_marrow | 0.70436939 |
| 112 | MP0009763_increased_sensitivity_to | 0.69472988 |
| 113 | MP0000249_abnormal_blood_vessel | 0.68863681 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.68813592 |
| 115 | MP0005390_skeleton_phenotype | 0.68527168 |
| 116 | MP0005166_decreased_susceptibility_to | 0.67553778 |
| 117 | MP0005165_increased_susceptibility_to | 0.65966065 |
| 118 | MP0003795_abnormal_bone_structure | 0.63023258 |
| 119 | MP0006036_abnormal_mitochondrial_physio | 0.61328777 |
| 120 | MP0003045_fibrosis | 0.61018300 |
| 121 | MP0008873_increased_physiological_sensi | 0.60205930 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58551134 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.58060627 |
| 124 | MP0003690_abnormal_glial_cell | 0.56076751 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.54576896 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.54408624 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.49525103 |
| 128 | MP0001542_abnormal_bone_strength | 0.49377546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.97060750 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.63512800 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.63448194 |
| 4 | Reticulocytopenia (HP:0001896) | 4.51745348 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 4.47755554 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.41997918 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.03417404 |
| 8 | Myositis (HP:0100614) | 3.92620627 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.62855390 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.62855390 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.62855390 |
| 12 | Pustule (HP:0200039) | 3.58939651 |
| 13 | Thrombocytosis (HP:0001894) | 3.46301679 |
| 14 | Agammaglobulinemia (HP:0004432) | 3.38484504 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 3.34512937 |
| 16 | Recurrent fungal infections (HP:0002841) | 3.29305451 |
| 17 | Chest pain (HP:0100749) | 3.27355849 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.27301202 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.23239974 |
| 20 | Pallor (HP:0000980) | 3.16340533 |
| 21 | IgM deficiency (HP:0002850) | 3.15395324 |
| 22 | Orchitis (HP:0100796) | 3.15302769 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.14926765 |
| 24 | Obstructive lung disease (HP:0006536) | 3.14926765 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.14215182 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.09785746 |
| 27 | Optic neuritis (HP:0100653) | 3.09785746 |
| 28 | Epistaxis (HP:0000421) | 3.02363823 |
| 29 | Macrocytic anemia (HP:0001972) | 3.01268015 |
| 30 | Recurrent viral infections (HP:0004429) | 3.01227756 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.00365559 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.00243052 |
| 33 | Vacuolated lymphocytes (HP:0001922) | 2.95559305 |
| 34 | Chronic otitis media (HP:0000389) | 2.87555080 |
| 35 | Recurrent skin infections (HP:0001581) | 2.84161471 |
| 36 | Petechiae (HP:0000967) | 2.84016074 |
| 37 | Spontaneous hematomas (HP:0007420) | 2.80738665 |
| 38 | Meningitis (HP:0001287) | 2.74087202 |
| 39 | Purpura (HP:0000979) | 2.60640085 |
| 40 | Gingival bleeding (HP:0000225) | 2.58586562 |
| 41 | Periodontitis (HP:0000704) | 2.58251518 |
| 42 | Gingivitis (HP:0000230) | 2.57957987 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.57671962 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.56848930 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.56490435 |
| 46 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.55930774 |
| 47 | Stomatitis (HP:0010280) | 2.53800138 |
| 48 | Prostate neoplasm (HP:0100787) | 2.51874204 |
| 49 | Autoimmune hemolytic anemia (HP:0001890) | 2.50579416 |
| 50 | Abnormality of T cells (HP:0002843) | 2.50266429 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.50173914 |
| 52 | Skin rash (HP:0000988) | 2.48716139 |
| 53 | Aplastic anemia (HP:0001915) | 2.48624833 |
| 54 | T lymphocytopenia (HP:0005403) | 2.47614255 |
| 55 | Recurrent cutaneous fungal infections (HP:0011370) | 2.47518774 |
| 56 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.47518774 |
| 57 | Arterial thrombosis (HP:0004420) | 2.47391039 |
| 58 | Exertional dyspnea (HP:0002875) | 2.47171845 |
| 59 | Abnormality of the pleura (HP:0002103) | 2.46763272 |
| 60 | Agnosia (HP:0010524) | 2.45067339 |
| 61 | Recurrent bronchitis (HP:0002837) | 2.44214192 |
| 62 | Hepatosplenomegaly (HP:0001433) | 2.44134665 |
| 63 | Amyloidosis (HP:0011034) | 2.41357649 |
| 64 | Increased serum ferritin (HP:0003281) | 2.41308394 |
| 65 | Vasculitis (HP:0002633) | 2.40856381 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.39728485 |
| 67 | Pulmonary embolism (HP:0002204) | 2.39471833 |
| 68 | Abnormality of the prostate (HP:0008775) | 2.36476073 |
| 69 | Cellulitis (HP:0100658) | 2.33394148 |
| 70 | Granulocytopenia (HP:0001913) | 2.31995193 |
| 71 | Loss of speech (HP:0002371) | 2.31089936 |
| 72 | Anorexia (HP:0002039) | 2.30963362 |
| 73 | Abnormal hemoglobin (HP:0011902) | 2.29669716 |
| 74 | Increased IgE level (HP:0003212) | 2.28898316 |
| 75 | Erythema (HP:0010783) | 2.28368353 |
| 76 | Colitis (HP:0002583) | 2.27731254 |
| 77 | Severe combined immunodeficiency (HP:0004430) | 2.27421514 |
| 78 | Urticaria (HP:0001025) | 2.27340090 |
| 79 | Eosinophilia (HP:0001880) | 2.25141035 |
| 80 | IgG deficiency (HP:0004315) | 2.24520068 |
| 81 | Type I transferrin isoform profile (HP:0003642) | 2.24489074 |
| 82 | Amaurosis fugax (HP:0100576) | 2.24279462 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.23771167 |
| 84 | Leukocytosis (HP:0001974) | 2.23740946 |
| 85 | 11 pairs of ribs (HP:0000878) | 2.23339457 |
| 86 | Osteomyelitis (HP:0002754) | 2.22966707 |
| 87 | Pulmonary fibrosis (HP:0002206) | 2.21526848 |
| 88 | Reduced antithrombin III activity (HP:0001976) | 2.20263055 |
| 89 | Combined immunodeficiency (HP:0005387) | 2.17853421 |
| 90 | Increased hepatocellular lipid droplets (HP:0006565) | 2.17518286 |
| 91 | Gangrene (HP:0100758) | 2.15113504 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.14527796 |
| 93 | Hypochromic anemia (HP:0001931) | 2.13727874 |
| 94 | Cheilitis (HP:0100825) | 2.13660261 |
| 95 | Prolonged bleeding time (HP:0003010) | 2.13176243 |
| 96 | Recurrent pneumonia (HP:0006532) | 2.11534689 |
| 97 | Keratoconjunctivitis sicca (HP:0001097) | 2.11386315 |
| 98 | Encephalitis (HP:0002383) | 2.10524887 |
| 99 | Skin ulcer (HP:0200042) | 2.10183053 |
| 100 | Basal ganglia calcification (HP:0002135) | 2.09911136 |
| 101 | Lymphoma (HP:0002665) | 2.07063775 |
| 102 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.06968243 |
| 103 | Poikiloderma (HP:0001029) | 2.06919729 |
| 104 | B lymphocytopenia (HP:0010976) | 2.06867361 |
| 105 | Abnormality of B cell number (HP:0010975) | 2.06867361 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 2.06850077 |
| 107 | Hypertensive crisis (HP:0100735) | 2.05952841 |
| 108 | Recurrent sinusitis (HP:0011108) | 2.05068023 |
| 109 | Abnormality of the preputium (HP:0100587) | 2.04707868 |
| 110 | Chromsome breakage (HP:0040012) | 2.04611175 |
| 111 | Panhypogammaglobulinemia (HP:0003139) | 2.04069204 |
| 112 | Lymphopenia (HP:0001888) | 2.03864235 |
| 113 | Hemoptysis (HP:0002105) | 2.03628910 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.02673571 |
| 115 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.01464082 |
| 116 | Abnormality of eosinophils (HP:0001879) | 1.98693227 |
| 117 | Polyneuropathy (HP:0001271) | 1.98091057 |
| 118 | Thrombophlebitis (HP:0004418) | 1.98014635 |
| 119 | Sparse eyelashes (HP:0000653) | 1.97990700 |
| 120 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.96502058 |
| 121 | Glomerulopathy (HP:0100820) | 1.96062351 |
| 122 | Sepsis (HP:0100806) | 1.95450995 |
| 123 | Chronic diarrhea (HP:0002028) | 1.95440645 |
| 124 | Inflammation of the large intestine (HP:0002037) | 1.95286744 |
| 125 | Keratoconjunctivitis (HP:0001096) | 1.94763384 |
| 126 | Abnormality of the pericardium (HP:0001697) | 1.94113146 |
| 127 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.94072334 |
| 128 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.94072334 |
| 129 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.94072334 |
| 130 | Thyroiditis (HP:0100646) | 1.93115855 |
| 131 | Increased IgM level (HP:0003496) | 1.90287708 |
| 132 | Respiratory difficulties (HP:0002880) | 1.90003802 |
| 133 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.88392257 |
| 134 | Parakeratosis (HP:0001036) | 1.86918967 |
| 135 | Premature loss of primary teeth (HP:0006323) | 1.85214890 |
| 136 | Anhidrosis (HP:0000970) | 1.85158498 |
| 137 | Recurrent lower respiratory tract infections (HP:0002783) | 1.83896167 |
| 138 | Pulmonary infiltrates (HP:0002113) | 1.83351993 |
| 139 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.82266346 |
| 140 | Lip pit (HP:0100267) | 1.81410384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.45875743 |
| 2 | BLK | 3.38821174 |
| 3 | MAP4K1 | 3.16872130 |
| 4 | IRAK4 | 2.94777268 |
| 5 | MAP3K14 | 2.72449610 |
| 6 | TXK | 2.64107894 |
| 7 | PIM2 | 2.55903033 |
| 8 | MST4 | 2.37058955 |
| 9 | TEC | 2.18299229 |
| 10 | IRAK3 | 2.14558424 |
| 11 | TYK2 | 2.14408137 |
| 12 | PBK | 2.05332471 |
| 13 | IKBKE | 2.04813137 |
| 14 | TNK2 | 2.02998784 |
| 15 | BCKDK | 1.97401009 |
| 16 | TBK1 | 1.89148163 |
| 17 | EIF2AK1 | 1.84546311 |
| 18 | BTK | 1.83998635 |
| 19 | KIT | 1.83900857 |
| 20 | IKBKB | 1.80042050 |
| 21 | TLK1 | 1.80012593 |
| 22 | JAK3 | 1.72838987 |
| 23 | RIPK4 | 1.66817000 |
| 24 | RPS6KA4 | 1.64961485 |
| 25 | ZAP70 | 1.60139274 |
| 26 | VRK2 | 1.53267719 |
| 27 | VRK1 | 1.53157697 |
| 28 | MST1R | 1.44869086 |
| 29 | CDK19 | 1.43633008 |
| 30 | STK10 | 1.42048555 |
| 31 | EIF2AK2 | 1.40645240 |
| 32 | SYK | 1.39169325 |
| 33 | EIF2AK3 | 1.34959824 |
| 34 | TGFBR2 | 1.31799779 |
| 35 | STK16 | 1.31232599 |
| 36 | ACVR1B | 1.30945661 |
| 37 | PIM1 | 1.27832919 |
| 38 | FGR | 1.15303271 |
| 39 | STK24 | 1.13639051 |
| 40 | RPS6KB2 | 1.13515516 |
| 41 | CSF1R | 1.13424501 |
| 42 | ITK | 1.11163206 |
| 43 | LYN | 1.10595177 |
| 44 | BUB1 | 1.10139506 |
| 45 | LCK | 1.08376683 |
| 46 | MAP3K13 | 1.06038355 |
| 47 | NEK9 | 1.04987829 |
| 48 | MAPKAPK3 | 1.03244238 |
| 49 | MAP2K6 | 1.02049952 |
| 50 | MAP3K3 | 1.01897125 |
| 51 | WEE1 | 1.00706767 |
| 52 | STK4 | 1.00308155 |
| 53 | CLK1 | 0.99536388 |
| 54 | YES1 | 0.97664818 |
| 55 | MAP3K11 | 0.96917276 |
| 56 | MAP3K12 | 0.94573756 |
| 57 | NLK | 0.93110319 |
| 58 | GRK7 | 0.89647068 |
| 59 | LRRK2 | 0.88531650 |
| 60 | NUAK1 | 0.87287106 |
| 61 | MAP3K1 | 0.86802879 |
| 62 | HCK | 0.86335848 |
| 63 | JAK1 | 0.84785474 |
| 64 | ADRBK2 | 0.83889258 |
| 65 | SCYL2 | 0.82474355 |
| 66 | TRPM7 | 0.81554101 |
| 67 | CHUK | 0.81384503 |
| 68 | TAOK1 | 0.80136649 |
| 69 | CSK | 0.77329674 |
| 70 | TAOK2 | 0.77263966 |
| 71 | MAP2K3 | 0.76979493 |
| 72 | TAOK3 | 0.75806784 |
| 73 | PRKCQ | 0.75624026 |
| 74 | AURKB | 0.75427926 |
| 75 | SMG1 | 0.75269159 |
| 76 | ZAK | 0.75139262 |
| 77 | KDR | 0.74658904 |
| 78 | ERN1 | 0.73318610 |
| 79 | PRPF4B | 0.70082463 |
| 80 | PDK1 | 0.69369845 |
| 81 | TGFBR1 | 0.66111759 |
| 82 | FLT3 | 0.65832868 |
| 83 | GRK6 | 0.65730617 |
| 84 | ATR | 0.61978590 |
| 85 | SRPK1 | 0.60880151 |
| 86 | PLK4 | 0.60284011 |
| 87 | FYN | 0.60169914 |
| 88 | MATK | 0.58786759 |
| 89 | MAPKAPK2 | 0.57075087 |
| 90 | PDPK1 | 0.56811661 |
| 91 | BMPR2 | 0.55170715 |
| 92 | RPS6KA6 | 0.53832664 |
| 93 | PRKD2 | 0.53079168 |
| 94 | NEK2 | 0.52961769 |
| 95 | MARK3 | 0.51831927 |
| 96 | CDK7 | 0.51634272 |
| 97 | TESK1 | 0.51214727 |
| 98 | BRSK2 | 0.50767928 |
| 99 | ARAF | 0.50728668 |
| 100 | CDC7 | 0.50584600 |
| 101 | DYRK3 | 0.50151382 |
| 102 | PRKCD | 0.48884014 |
| 103 | ABL2 | 0.48646674 |
| 104 | JAK2 | 0.48280282 |
| 105 | PIK3CG | 0.47708619 |
| 106 | RPS6KA5 | 0.47372477 |
| 107 | PRKG2 | 0.47147883 |
| 108 | ABL1 | 0.46961024 |
| 109 | RPS6KC1 | 0.46901885 |
| 110 | RPS6KL1 | 0.46901885 |
| 111 | DAPK1 | 0.46305751 |
| 112 | MAPK7 | 0.44513749 |
| 113 | MAPK12 | 0.43517942 |
| 114 | FES | 0.42929782 |
| 115 | BMPR1B | 0.42499272 |
| 116 | HIPK2 | 0.42119017 |
| 117 | GRK1 | 0.41616824 |
| 118 | CDK4 | 0.40994125 |
| 119 | TESK2 | 0.40697132 |
| 120 | MAP2K2 | 0.38711119 |
| 121 | CDK8 | 0.38582353 |
| 122 | MKNK1 | 0.36704279 |
| 123 | IRAK1 | 0.36251775 |
| 124 | CSNK2A1 | 0.35752902 |
| 125 | MAPK4 | 0.35517993 |
| 126 | CDK6 | 0.35371321 |
| 127 | MAPK11 | 0.34835810 |
| 128 | IRAK2 | 0.29452722 |
| 129 | MAP3K5 | 0.28082131 |
| 130 | EPHB1 | 0.28076154 |
| 131 | IGF1R | 0.26001235 |
| 132 | MAP3K6 | 0.25181073 |
| 133 | MAPK3 | 0.24597839 |
| 134 | ADRBK1 | 0.21914528 |
| 135 | PTK6 | 0.21815117 |
| 136 | PRKD1 | 0.21194746 |
| 137 | RPS6KA2 | 0.20845145 |
| 138 | GRK5 | 0.20788717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.58322348 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.10058834 |
| 3 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.55994764 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.38448466 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31486654 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.28638174 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.20313326 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.13402085 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.08248958 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.99418084 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.96601601 |
| 12 | Base excision repair_Homo sapiens_hsa03410 | 1.91149162 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.83154443 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76024581 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73862970 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.69194731 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.67453552 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65219869 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64267384 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59109638 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59098555 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 1.55733229 |
| 23 | * Legionellosis_Homo sapiens_hsa05134 | 1.51401022 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.48946066 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48648593 |
| 26 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.46400248 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41893677 |
| 28 | * Pertussis_Homo sapiens_hsa05133 | 1.41383860 |
| 29 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40307814 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39142577 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.36160894 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.32398632 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.28268936 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 1.27456277 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.24580470 |
| 36 | * Influenza A_Homo sapiens_hsa05164 | 1.23049540 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18980559 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17984184 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.13778832 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.13206831 |
| 41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.08759124 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08111300 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05841837 |
| 44 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03578123 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.02889667 |
| 46 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00639627 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99992961 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98100478 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.93938909 |
| 50 | * Salmonella infection_Homo sapiens_hsa05132 | 0.91296078 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90664003 |
| 52 | Protein export_Homo sapiens_hsa03060 | 0.90565729 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90067439 |
| 54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89834787 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89684515 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86426924 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.83958142 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82551746 |
| 59 | RNA degradation_Homo sapiens_hsa03018 | 0.81722610 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81567051 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78407851 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78322452 |
| 63 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78040176 |
| 64 | Basal transcription factors_Homo sapiens_hsa03022 | 0.76744809 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76151060 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.75734659 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75019701 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.73486676 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72086512 |
| 70 | Cell cycle_Homo sapiens_hsa04110 | 0.71031458 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70724991 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70629977 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70499466 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.67789863 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.67532940 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65659790 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64449424 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64342505 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63139426 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60781936 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60704285 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59883626 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.59296036 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58858000 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58245053 |
| 86 | Phagosome_Homo sapiens_hsa04145 | 0.58226267 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.57665269 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56425064 |
| 89 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56058344 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56039672 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51375746 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.50984153 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50729592 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49924195 |
| 95 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49752578 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48273717 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46160245 |
| 98 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44958873 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.44851145 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40972866 |
| 101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40067250 |
| 102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39962837 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.39804108 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38512137 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37281459 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37236016 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36960644 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33788194 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.31825653 |
| 110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31804890 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30662038 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30352384 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29323834 |
| 114 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27530662 |
| 115 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.24992675 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22177898 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22005345 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21353283 |
| 119 | Peroxisome_Homo sapiens_hsa04146 | 0.17467882 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.16431304 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15542173 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12570143 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12035834 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08377736 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.08235160 |

